ストックスクリーナーアプリを入手
1.91
4.98%
-0.10
プレマーケット:
1.90
-0.01
-0.52%
前日終値:
$2.01
開ける：
$2.02
24時間の取引高:
413.40K
Relative Volume:
0.91
時価総額：
$50.78M
収益：
$155.00K
当期純損益:
$-30.01M
株価収益率:
-1.1437
EPS:
-1.67
ネットキャッシュフロー:
$-11.98M
1週間 パフォーマンス:
-6.37%
1か月 パフォーマンス:
+34.51%
6か月 パフォーマンス:
-75.19%
1年 パフォーマンス:
-59.79%
1日の値動き範囲:
$1.86
$2.02
1週間の範囲:
$1.86
$2.30
52週間の値動き範囲:
$1.38
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
名前
Inmune Bio Inc
セクター
電話
(858) 964-3720
住所
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
INMB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.91 | 53.44M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-01 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-07-01 | ダウングレード | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
| 2024-10-21 | 開始されました | Alliance Global Partners | Buy |
| 2024-09-27 | 開始されました | Raymond James | Outperform |
| 2024-08-22 | 開始されました | Scotiabank | Sector Outperform |
| 2023-06-01 | 開始されました | Robert W. Baird | Outperform |
| 2022-05-24 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | 繰り返されました | Maxim Group | Buy |
| 2021-04-21 | 開始されました | B. Riley Securities | Buy |
| 2021-01-22 | 繰り返されました | Maxim Group | Buy |
| 2020-09-01 | 開始されました | BTIG Research | Buy |
| 2020-07-15 | 繰り返されました | H.C. Wainwright | Buy |
すべてを表示
Inmune Bio Inc (INMB) 最新ニュース
INmune Bio (NASDAQ:INMB) Rating Increased to Hold at Wall Street Zen - MarketBeat
Aug Closing: Is INmune Bio Inc stock resilient to inflationTrade Risk Report & Expert Verified Movement Alerts - moha.gov.vn
Praetorian PR LLC Sells 863,000 Shares of INmune Bio, Inc. $INMB - MarketBeat
Inmune Bio Ends Sales Agreement with RBC and BTIG - TipRanks
Can INmune Bio Stock Hold Up When Markets Turn? - Trefis
Can INmune Bio (NASDAQ:INMB) Afford To Invest In Growth? - Sahm
Would You Still Hold INmune Bio Stock If It Fell 30%? - Trefis
Inmune Bio Unveils Promising Alzheimer’s Trial Data - MSN
Insider Sell: Why INmune Bio Inc stock could see breakout soonJuly 2025 Momentum & AI Enhanced Market Trend Forecasts - moha.gov.vn
Retail Trends: Can INmune Bio Inc stock beat analyst upgradesMarket Activity Report & Verified Chart Pattern Signals - BỘ NỘI VỤ
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as Inmune Bio's CORDStrom?? Platform - marketscreener.com
INMB: INmune Bio Highlights Future Potential of MSC Therapies - GuruFocus
INmune Bio, Inc. Announces Publication on Future Applications of Mesenchymal Stromal Cell Therapies - Quiver Quantitative
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform - The Manila Times
INmune Bio Inc Stock Analysis and ForecastSell Signals and Alerts & Turn Data into Profits With Our Strategies - earlytimes.in
Inmune Bio Updates Executive Employment Agreements - TipRanks
INMB SEC FilingsInmune Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Could INmune Bio Unlock Value With Upcoming Regulatory Catalysts And Clinical Readouts? - RTTNews
Why INmune Bio Inc. stock could see breakout soonWeekly Loss Report & Daily Momentum Trading Reports - Newser
Can INmune Bio Inc. stock beat analyst upgradesStock Surge & Free Technical Confirmation Trade Alerts - Newser
Can INmune Bio Stock Recover If Markets Fall? - Trefis
Can INmune Bio Inc. stock sustain revenue growthJuly 2025 News Drivers & AI Powered Buy and Sell Recommendations - Newser
INmune Bio reports promising Alzheimer’s drug data at CTAD conference By Investing.com - Investing.com Canada
INmune Bio stock falls after new Alzheimer’s trial data By Investing.com - Investing.com Nigeria
INmune Bio stock falls after new Alzheimer’s trial data - Investing.com
INmune Bio (INMB) Reveals Promising Phase 2 Neuroimaging Data for Alzheimer's Treatment - GuruFocus
INmune Bio (INMB) Reveals Promising Phase 2 Neuroimaging Data fo - GuruFocus
INmune Bio reports promising Alzheimer’s drug data at CTAD conference - Investing.com
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer's Patients - The Manila Times
INmune Bio, Inc. Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595?s Evidence Base in High-Inflammation Alzheimer's Patients - marketscreener.com
What drives INmune Bio Inc stock priceREITs Market Trends & Consistent High Yield Stocks - earlytimes.in
Inmune Bio announces new executive employment agreements with compensation details - Investing.com Nigeria
Inmune Bio announces new executive employment agreements with compensation details By Investing.com - Investing.com South Africa
Inmune Bio Announces New Executive Employment Agreements - TipRanks
How INmune Bio Inc. stock performs in high volatility marketsTrade Volume Summary & Technical Pattern Alert System - moha.gov.vn
Block Trades: Why analysts upgrade INmune Bio Inc. stockTrade Analysis Report & High Win Rate Trade Alerts - BỘ NỘI VỤ
Is INmune Bio Inc. stock positioned for long term growth2025 Technical Overview & Technical Buy Zone Confirmation - newser.com
Analyzing recovery setups for INmune Bio Inc. investorsMarket Sentiment Report & Verified Swing Trading Watchlist - newser.com
Is INmune Bio Inc. a candidate for recovery playWeekly Gains Report & Consistent Profit Alerts - newser.com
Why INmune Bio Inc. stock is a value investor pickRisk Management & Daily Entry Point Alerts - newser.com
Heatmap analysis for INmune Bio Inc. and competitorsWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com
Short interest data insights for INmune Bio Inc.Market Trend Review & Verified Technical Signals - newser.com
How INmune Bio Inc. stock benefits from global expansionMarket Sentiment Summary & Reliable Price Action Trade Plans - newser.com
Inmune Bio Inc (INMB) 財務データ
収益
当期純利益
現金流量
EPS
0.36%
1.05%
大文字化:
|
ボリューム (24 時間):